retatrutide obesity treatment VisualAbstract: reduces body weight by 17.5% in patients with Retatrutide for weight loss: Study

Resuming GLP-1 Medications Post-Pregnancy: The timeline for resuming GLP-1 medications post-pregnancy is an intricate decision

PMID: 23 CarliF.Della PepaG.SabatiniS.Vidal PuigA.GastaldelliA

Preparation and biomedical applications of silk fibroin-nanoparticles composites with enhanced properties-a review

The increasing investments by private investors and government bodies for research purposes, focus on developing strategies for expanding health workforce, rising awareness and early detection programs for high-risk individuals, combination therapies for glycemic control, and stringent regulatory guidelines are the factors boosting the market growth of this segment

This helps prevent condensation inside the vial and ensures the powder dissolves more easily and evenly

However, for individuals with higher starting weight, medication alone is often not enough to achieve the degree of weight loss needed to reach a healthier range